Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line teratment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice

M (Michel) van Agthoven; S Wittebol; LM (Leo) Budel; Carin Uyl - de Groot; MHH Kramer

Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line teratment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice

M (Michel) van Agthoven
, S Wittebol
, LM (Leo) Budel
, Carin Uyl - de Groot
, MHH Kramer

External organisation

Research output: Contribution to journal › Article › Academic

Original language	Undefined/Unknown
Pages (from-to)	88-93
Number of pages	6
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	148
Publication status	Published - 2004

Research programs

EMC NIHES-05-63-02 Quality

Cite this

@article{07ffa18118aa4ce2b3f81724f241b03e,

title = "Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line teratment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice",

author = "\{van Agthoven\}, \{M (Michel)\} and S Wittebol and Budel, \{LM (Leo)\} and \{Uyl - de Groot\}, Carin and MHH Kramer",

year = "2004",

language = "Undefined/Unknown",

volume = "148",

pages = "88--93",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Vereniging Nederlands Tijdschrift voor Geneeskunde",

}

Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line teratment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice. / van Agthoven, M (Michel); Wittebol, S; Budel, LM (Leo) et al.
In: Nederlands Tijdschrift voor Geneeskunde, Vol. 148, 2004, p. 88-93.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line teratment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice

AU - van Agthoven, M (Michel)

AU - Wittebol, S

AU - Budel, LM (Leo)

AU - Uyl - de Groot, Carin

AU - Kramer, MHH

PY - 2004

Y1 - 2004

M3 - Article

SN - 0028-2162

VL - 148

SP - 88

EP - 93

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

ER -